WealthPLAN Partners’s Chemours CC Stock Holding History

WealthPLAN Partners’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-22	Closed	-$808	–	213
2017 Q1	$808	Buy	+22	New	+$662	﹤0.01%	437
2016 Q3	$4.79K	Sell	307 -305	-50%	-$3.48K	﹤0.01%	721
2016 Q2	$2.53K	Buy	+612	New	+$5.45K	﹤0.01%	2194
2015 Q4	$32	Buy	+18	New	+$115	﹤0.01%	1691

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

WealthPLAN Partners's CC Position: Q2 2017 in Review

WealthPLAN Partners sold out of Chemours (CC) in Q2 2017, closing a stake of 22 shares — an estimated $808 sold.

WealthPLAN Partners first reported a position in CC in Q4 2015 and held it in 4 quarters. The position peaked at $4.79K in Q3 2016. 463 funds tracked by Wall St. Rank hold CC as of Q2 2017.

WealthPLAN Partners reported no remaining Chemours position as of Q2 2017 after selling out during the quarter.
WealthPLAN Partners sold 22 Chemours shares in Q2 2017, an estimated $808.
WealthPLAN Partners first reported a position in Chemours in Q4 2015 and held it in 4 quarters.
WealthPLAN Partners's Chemours position peaked at $4.79K in Q3 2016.
463 funds tracked by Wall St. Rank held Chemours as of Q2 2017.

Based on WealthPLAN Partners's 13F filing for Q2 2017, filed 11 Aug 2017.